Currently, genic variation in ADPKD is the main factor predicting renal outcome, ESRF occurring up to 15–20 years later in patients with a PKD2 mutation when compared to those with a PKD1 mutation [7]. This evidence concerns the gene PKD2 and autosomal dominant polycystic kidney disease.